Literature DB >> 7954384

The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals.

D Irvine1, L Vincent, J E Graydon, N Bubela, L Thompson.   

Abstract

Fatigue can be a prevalent and serious problem for the individual with cancer and can negatively impact on the individual's quality of life. Little is known about the prevalence of clinical fatigue among patients with cancer and how the fatigue cancer patient's experience compares with the fatigue people experience as a function of their normal daily activities. This study, which utilized a control group, investigated the prevalence of fatigue among patients receiving treatment with radiotherapy (n = 54) and chemotherapy (n =47) over two measurement points. The level of fatigue experienced by cancer patients was compared with the level of fatigue experienced by apparently healthy auxiliary staff (n = 53) working at three cancer treatment facilities. There were no differences in the mean level of fatigue experienced by cancer patients and the mean level experienced by healthy controls before the start of cancer treatment. However, cancer patients experienced a significant increase in fatigue over a 5- or 6-week course of radiotherapy and 14 days after treatment with chemotherapy, and these increases were significantly greater than the fatigue reported by healthy control subjects. The midpoint of the Pearson Byars Fatigue Feeling Checklist was accepted as a crude measure of clinical fatigue and was found to be significantly different from the mean level of fatigue reported by healthy controls. The prevalence of fatigue among patients after undergoing cancer treatment was determined to be 61%. Fatigue in cancer patients was found to covary with weight, symptom distress, mood disturbance, and alterations in usual functional activities. The best predictors of fatigue in the patient sample were their symptom distress and mood disturbance. Symptom distress and fatigue were significant predictors of impairment in functional activities related to illness. Implications for practice and future research are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 7954384

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  68 in total

1.  A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer.

Authors:  Glenn J Lesser; Doug Case; Nancy Stark; Susan Williford; Jeff Giguere; L Astrid Garino; Michelle J Naughton; Mara Z Vitolins; Mark O Lively; Edward G Shaw
Journal:  J Support Oncol       Date:  2013-03

2.  Ecological momentary assessment of fatigue following breast cancer treatment.

Authors:  Shelly L Curran; Abbie O Beacham; Michael A Andrykowski
Journal:  J Behav Med       Date:  2004-10

3.  Fatigue patterns and correlates in male liver cancer patients receiving transcatheter hepatic arterial chemoembolization.

Authors:  Shiow-Ching Shun; Yeur-Hur Lai; Ting-Ting Jing; Chii Jeng; Fa-Yau Lee; Li-Shia Hu; Sue-Yueh Cheng
Journal:  Support Care Cancer       Date:  2004-12-21       Impact factor: 3.603

4.  Cancer-related fatigue: new theories?

Authors:  Agnes Glaus
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

5.  Curing the cure: utilizing exercise to limit cardiotoxicity.

Authors:  Craig A Emter; Douglas K Bowles
Journal:  Med Sci Sports Exerc       Date:  2008-05       Impact factor: 5.411

6.  Trajectories of fatigue in patients with breast cancer before, during, and after radiation therapy.

Authors:  Anand Dhruva; Marylin Dodd; Steven M Paul; Bruce A Cooper; Kathryn Lee; Claudia West; Bradley E Aouizerat; Patrick S Swift; William Wara; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2010 May-Jun       Impact factor: 2.592

7.  Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer.

Authors:  Cielito C Reyes-Gibby; Lu Ann Aday; Karen O Anderson; Tito R Mendoza; Charles S Cleeland
Journal:  J Pain Symptom Manage       Date:  2006-08       Impact factor: 3.612

Review 8.  [Aerobic endurance training for cancer patients].

Authors:  Richard Crevenna; Christoph Zielinski; Mohammad Yahya Keilani; Manuela Schmidinger; Christian Bittner; Martin Nuhr; Hakan Nur; Christine Marosi; Veronika Fialka-Moser; Michael Quittan
Journal:  Wien Med Wochenschr       Date:  2003

Review 9.  Supportive care for patients with early breast cancer.

Authors:  Laura García-Estévez; Ignasi Tusquets; Isabel Alvarez; César Rodríguez; Yolanda Fernández; Miguel Angel Seguí; Jesús García-Mata; Ana Lluch
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

10.  Trajectories of fatigue in men with prostate cancer before, during, and after radiation therapy.

Authors:  Christine Miaskowski; Steven M Paul; Bruce A Cooper; Kathryn Lee; Marylin Dodd; Claudia West; Bradley E Aouizerat; Patrick S Swift; William Wara
Journal:  J Pain Symptom Manage       Date:  2008-03-20       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.